Treatment of cancer using a smad3 inhibitor
作者： Hui Yao Lan
DOI:
关键词:
摘要: The present invention resides in the discovery that Smad3, a key downstream mediator of TGF-β signaling, plays critical role development and progression cancer. Thus, this application provides for novel method treating cancer by inhibiting Smad3 such as through administration SIS3, an inhibitor Smad3. Further provided are compositions kits useful way signaling.
lens.org 参考文章(35)
Brett P. Monia, Lex M. Cowsert, Antisense modulation of smad3 expression ,(1999)
Masayori Inouye, Experimental manipulation of gene expression Academic Press. ,(1983)
Gillian Ashcroft, James Mitchell, Anita Roberts, Angelo Russo, Inhibition of Smad3 to prevent fibrosis and improve wound healing ,(2002)
Hiroaki Ikushima, Tomoki Todo, Keiji Miyazawa, Kohei Miyazono, Yasushi Ino, Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor ,(2010)
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Jonathan A. Ellman, Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support ,(1992)
Kelly Sprankle, John Kiely, Phillip Dan Cook, Peptide nucleic acid combinatorial libraries and improved methods of synthesis ,(1995)
Hao Chen, Richard J. Radmer, Generation and screening of synthetic drug libraries ,(1995)
Francis C. Szoka, Jean Haensler, Self-assembling polynucleotide delivery system ,(1993)
Victor J. Hruby, Sydney E. Salmon, Kit Sang Lam, Fahad Al-Obeidi, Evan M. Hersh, Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof ,(1991)